FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to inflectional diseases, and can be applied for treatment of patients with haemorrhagic fever with renal syndrome of medium- severe forms. For this purpose traditional basic therapy is carried out and since first day of disease additionally by intravenously drip introduced is medication emoxypin. Since 6-th day of therapy 1% emoxypin is introduced intramuscularly in amount 0.5 ml 2 times per day during 10 days.
EFFECT: method insures reduction of treatment terms, also due to improvement of nitrogen-excretion renal function, reduction of endotoxicosis, improvement of oxidative reactions and immunomodulaton.
7 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF PATIENTS WITH HEMORRHAGIC FEVER WITH RENAL SYNDROME IN CASE OF LIVER DYSFUNCTION DEVELOPMENT | 2016 |
|
RU2645067C1 |
| METHOD FOR TREATMENT OF HEMORRHAGIC FEVER WITH RENAL SYNDROME OF AVERAGELY SEVERE AND SEVERE FORMS | 2005 |
|
RU2289456C1 |
| METHOD OF SEVERITY ASSESSMENT FOR HEMORRHAGIC FEVER WITH RENAL SYNDROME | 2009 |
|
RU2392858C1 |
| METHOD FOR EVALUATING INTOXICATION DEGREE IN CHILDREN WITH PURULENT-SEPTIC DISEASES | 2006 |
|
RU2319149C2 |
| METHOD FOR EVALUATING HEMORRHAGIC FEVER SEVERITY WHEN AGGRAVATED WITH RENAL SYNDROME | 1998 |
|
RU2155337C1 |
| METHOD FOR TREATMENT OF HEMORRHAGIC FEVER WITH RENAL SYNDROME | 2002 |
|
RU2228196C1 |
| METHOD TO TREAT HEMORRHAGIC FEVER AT RENAL SYNDROME | 2000 |
|
RU2181046C2 |
| METHOD FOR EVALUATING THE SEVERITY OF HEMORRHAGIC FEVER FLOW ACCOMPANIED WITH RENAL SYNDROME | 2003 |
|
RU2245552C1 |
| METHOD OF PREDICTING DEVELOPMENT OF COMPLICATIONS OF HEMORRHAGIC FEVER WITH RENAL SYNDROME IN EARLY PERIOD OF DISEASE | 2010 |
|
RU2433407C1 |
| METHOD FOR PREDICTION OF SEVERITY OF HAEMORRHAGIC FEVER WITH RENAL SYNDROME BY C-REACTIVE PROTEIN | 2024 |
|
RU2828321C1 |
